Worst performer by a long way was PAF:Pan African Resources, dropping 23% after an operational update that wasn't really bad. I guess given all gold miners were hammered this week, it's not a surprise. I took advantage of the drop to buy some more.
EDV:Endeavour Mining dropped 13% and is now only 4% in profit, which is amazing given the price of gold.
PRU:Prudential fell 12% and are now at a loss by 3%. It sounds like investors were spooked by performance in China.
THX:Thor Explorations also dropped 12% following the trend amongst miners.
ATYM:Atalya Mining fell 10% and my ISA holding is no longer in profit.
FRES:Fresnillo and GGP:Greatland Resources both fell 9% which was pretty good compared to the rest.
FDM:FDM Group fell 7% after a recent rally and are now 68% down.
AMRQ:Amaroq, FNX:Fonix and HPOW:H-Power all fell 6%.
GAW:Games Workshop, INVP:Investec and JHD:James Halstead all fell 5%, which is especially surprising for INVP, having just been announced as a FTSE 100 entry.
There was some good news
BTG:BTG Consulting went up 7%, and 5% into profit after announcing an acquisition.
AMP:Ampeak Energy went up 13% for no obvious reason, but are still 67% down.
IES:Invinity Energy are still on a roll and went up another 13% this week. It's now even looking possible I may not make a loss on them, which I never would have thought a few years ago. My recent holding is up by 76% and I deeply regret just matching the value of my old holding, as I could have broken even by now if I'd got more at the cheap price. As it is, I need it to double again from here to break even.
Share of the Week is PBX:Probiotix Health, which seems to have had a delayed reaction to recent contract news and went up 15% this week after a 10% drop last week. Whether it will continue to climb is another question though.
Here's the ISA and shares portfolio after week 45 of year 11.
| Weekly Change | |||
| Cash | £109.73 | -£3.81 | |
| Portfolio cost | £116,490.29 | +£0 | |
| Portfolio sell value (bid price-commission) | £32,791.37 | (-71.9%) | +£285.73 |
| Potential profits | £456.04 | -£43.92 | |
| Yr 11 Dividends | £86.83 | +£0 | |
| Yr 11 Interest | £1.57 | +£0 | |
| Yr 11 Profit from sales | £873.14 | +£0 | |
| Yr 11 proj avg monthly profit | £84.70 | (1.2%) | -£2.30 |
| Total Dividends | £12,574.90 | +£0 | |
| Total Interest | £10.14 | +£0 | |
| Total Profit from sales | £18,433.41 | +£0 | |
| Average monthly cash profit | £232.93 | (3.2%) | -£0.44 |
| (Sold stocks profit + Dividends - Fees / Months) |
The portfolio value actually increased by £285 thanks to IES:Invinity Energy and PBX:Probiotix Health, although the big drops in HPOW:H-Power and AMRQ:Amaroq meant potential profits dropped by £43.
Still pretty flat.
Hugging the trend line
The SIPP looks like this after week 549 overall and week 29 of year 11.
| Weekly Change | ||||
| Cash | £1,292.07 | +£435.99 | ||
| Portfolio cost | £159,720.80 | +£180.21 | ||
| Portfolio sell value (bid price - commission) | £89,357.39 | (-44.1%) | -£4,031.66 | |
| Potential profits | £10,217.64 | -£3,297.16 | ||
| Yr 11 Dividends | £1.407.58 | +£197.78 | ||
| Yr 11 Interest | £12.26 | +£0 | ||
| Yr 11 Profit from sales | £9,397.72 | +£180.92 | ||
| Yr 11 proj avg monthly profit | £1,597.39 | (19.4%) | -£0.38 | |
| Total Dividends | £19,627.78 | +£197.78 | ||
| Total Interest | £32.96 | +£0 | ||
| Total Profit from sales | £34,064.23 | +£180.92 | ||
| Average monthly cash profit | £410.26 | (5.0%) | +£2.15 |
I added £250 injection for monthly savings and got £71 dividend from FOUR:4imprint, £23 from both JHD:James Halstead and KAIN:Kainos Group, and £79 from SBRE:Sabre Insurance, so cash is up. Big drop in portfolio value though, most of which was potential profits.
I sold my 81 shares in SCT:Softcat for 1824.7013p and made £180.92 (13.9%) profit. Given I've now accepted I have a curse, they rocketed the day after to 1864p which would have given me another £30. I bought 1,272 shares in PAF:Pan African Resources with the proceeds at 114.78p costing £1,472.30. They promptly dropped 7% to 106p.
The combination of small profit and dividends was enough to keep year 11 performance pretty flat, and improved long term performance by £2 a month. I hope to get to the stage where I can maintain 5% on dividends alone and the rest will be bonus selling for profit. That won't happen until I can offload the non-dividend shares.
I'll never get to cross that bloody injection line!
Very grim
The up-tick isn't enough to take us back above the trend line.
A depressing week, but I think we're stuck in a period of intense volatility for a while longer yet.
I'll never get to cross that bloody injection line!
Very grim
The up-tick isn't enough to take us back above the trend line.
A depressing week, but I think we're stuck in a period of intense volatility for a while longer yet.
No comments:
Post a Comment